Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-11-22

Clinical Trial Update: Study to Evaluate the Efficacy and Tolerability of Venaflon Use in Reducing the Symptoms Caused by Chronic Venous Insufficiency When Compared With Daflon [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and tolerability of Venaflon versus Daflon for symptoms of chronic venous insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daflon (diosmin + hesperidin)
  • Venaflon

Snippet

Sponsor: Laboratório Teuto Brasileiro S/A | Conditions: Chronic Venous Insufficiency, Disease | Phase 3 | Status: UNKNOWN